Barbexaclone
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Ffffrr (talk | contribs) at 15:00, 25 April 2022 (Importing Wikidata short description: "Chemical compound" (Shortdesc helper)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:00, 25 April 2022 by Ffffrr (talk | contribs) (Importing Wikidata short description: "Chemical compound" (Shortdesc helper))
Chemical compound
![]() | |
Combination of | |
---|---|
Phenobarbital | Barbiturate |
Levopropylhexedrine | Stimulant (sympathomimetic) |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.022.278 ![]() |
![]() ![]() |
Barbexaclone (Maliasin) is a salt compound of phenobarbital and levopropylhexedrine.[1] It was introduced in 1983. It has been reported to be as effective as phenobarbital but better tolerated; however, as of 2004, these "promising results"[2] had not yet been confirmed nor denied in controlled trials.
Potency
100 mg of barbexaclone is equivalent to 60 mg of phenobarbital.[1]
References
- ^ a b Shorvon S, Perucca E, Engel Jr J (23 September 2015). The Treatment of Epilepsy. Wiley. pp. 1706–1707. ISBN 978-1-118-93699-3.
- ^ Salles Barbosa MF (September 1978). "[Barbexaclone in the treatment of cerebral dysrhythmia]". Arquivos de Neuro-Psiquiatria. 36 (3): 245–9. doi:10.1590/s0004-282x1978000300009. PMID 28716.
Further reading
- Shorvon SR, Fish DR, Perucca E, Dodson WE, eds. (2004). The Treatment of Epilepsy (2nd ed.). Published by Blackwell. p. 472. ISBN 0-632-06046-8.
GABAA |
| ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GABAB | |||||||||||||||||||||||||
H1 |
| ||||||||||||||||||||||||
α2-Adrenergic | |||||||||||||||||||||||||
5-HT2A |
| ||||||||||||||||||||||||
Melatonin | |||||||||||||||||||||||||
Orexin | |||||||||||||||||||||||||
α2δ VDCC | |||||||||||||||||||||||||
Others |
Adamantanes | |
---|---|
Adenosine antagonists | |
Alkylamines | |
Ampakines | |
Arylcyclohexylamines | |
Benzazepines | |
Cathinones |
|
Cholinergics |
|
Convulsants | |
Eugeroics | |
Oxazolines | |
Phenethylamines |
|
Phenylmorpholines | |
Piperazines | |
Piperidines |
|
Pyrrolidines | |
Racetams | |
Tropanes |
|
Tryptamines | |
Others |
|
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed DrugBank identifier
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Drugs that are a combination of chemicals
- All stub articles